Chubb Toekomstige groei
Future criteriumcontroles 0/6
De omzet van Chubb zal naar verwachting dalen met 0.05% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 0.7% per jaar. De winst per aandeel zal naar verwachting groeien met 2.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.8% zijn.
Belangrijke informatie
0.7%
Groei van de winst
2.9%
Groei van de winst per aandeel
Insurance winstgroei | 8.2% |
Inkomstengroei | -0.05% |
Toekomstig rendement op eigen vermogen | 12.8% |
Dekking van analisten | Good |
Laatst bijgewerkt | 04 Nov 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Chubb's 20-Year Outperformance Continues As Market Winds Change
Oct 25Chubb: One More Reason For Potential Buyout By Berkshire
Oct 12Chubb: Encouraging Industry Outlook Supports Growth
Sep 18Chubb: A Profitable Global Insurer With An Overheated Bull Run, Awaiting Cooler Days
Sep 06Chubb Delivers Solid Q2 Results As Investment Tailwind Persists
Jul 25Chubb: 3 Reasons Why A Full Buyout By Berkshire Is A Possibility
Jun 20Why Investors Shouldn't Be Surprised By Chubb Limited's (NYSE:CB) Low P/E
Jun 16Chubb: Berkshire Is Right To Buy This Great Company At A Good Price
May 16We Think Some Shareholders May Hesitate To Increase Chubb Limited's (NYSE:CB) CEO Compensation
May 10Chubb Limited: Where Impressive Becomes The New Norm
Apr 25Chubb: Strong Underwriting Provides Moderate Upside [Downgrade]
Mar 27Chubb: Shares Breakout, Remain Undervalued, Earnings On Tap
Jan 22Investors Continue Waiting On Sidelines For Chubb Limited (NYSE:CB)
Jan 08Here's Why We Think Chubb (NYSE:CB) Is Well Worth Watching
Nov 13Chubb: Outstanding Stock, But Market Has Already Priced In
Nov 09Chubb: A Best In Breed Stock After Strong Q3 Earnings
Oct 25Chubb: A Value Opportunity, Buy Rating Reaffirmed
Oct 06Chubb: A Relatively Cheap Savehaven
Sep 11Chubb: Opportunity To Buy An Insurer In Strong Financial Condition
Jul 03Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 51,408 | 10,279 | N/A | 13,081 | 9 |
12/31/2025 | 48,976 | 9,569 | N/A | 14,113 | 9 |
12/31/2024 | 45,920 | 8,977 | N/A | 15,327 | 9 |
9/30/2024 | 54,697 | 9,997 | 14,803 | 14,803 | N/A |
6/30/2024 | 53,619 | 9,716 | 15,165 | 15,165 | N/A |
3/31/2024 | 51,791 | 9,279 | 13,601 | 13,601 | N/A |
12/31/2023 | 49,695 | 9,028 | 12,632 | 12,632 | N/A |
9/30/2023 | 48,336 | 7,039 | 12,104 | 12,104 | N/A |
6/30/2023 | 46,508 | 5,788 | 10,858 | 10,858 | N/A |
3/31/2023 | 44,173 | 5,185 | 11,065 | 11,065 | N/A |
12/31/2022 | 42,812 | 5,246 | 11,258 | 11,258 | N/A |
9/30/2022 | 41,342 | 6,076 | 11,200 | 11,200 | N/A |
6/30/2022 | 40,134 | 7,117 | 11,088 | 11,088 | N/A |
3/31/2022 | 40,170 | 8,192 | 11,488 | 11,488 | N/A |
12/31/2021 | 40,507 | 8,525 | 11,151 | 11,151 | N/A |
9/30/2021 | 40,288 | 8,816 | 11,093 | 11,093 | N/A |
6/30/2021 | 39,061 | 8,177 | 11,315 | 11,315 | N/A |
3/31/2021 | 38,386 | 5,581 | 10,178 | 10,178 | N/A |
12/31/2020 | 36,535 | 3,533 | 9,785 | 9,785 | N/A |
9/30/2020 | 34,916 | 2,288 | 8,670 | 8,670 | N/A |
6/30/2020 | 34,466 | 2,185 | 7,331 | 7,331 | N/A |
3/31/2020 | 33,965 | 3,666 | 6,732 | 6,732 | N/A |
12/31/2019 | 34,230 | 4,454 | 6,342 | 6,342 | N/A |
9/30/2019 | 33,074 | 3,636 | 6,496 | 6,496 | N/A |
6/30/2019 | 32,772 | 3,776 | 5,991 | 5,991 | N/A |
3/31/2019 | 32,748 | 3,920 | 6,251 | 6,251 | N/A |
12/31/2018 | 32,679 | 3,962 | 5,480 | 5,480 | N/A |
9/30/2018 | 33,115 | 5,140 | 4,989 | 4,989 | N/A |
6/30/2018 | 33,013 | 3,839 | N/A | 5,060 | N/A |
3/31/2018 | 32,637 | 3,850 | N/A | 4,041 | N/A |
12/31/2017 | 32,340 | 3,861 | N/A | 4,503 | N/A |
9/30/2017 | 32,455 | 3,938 | N/A | 4,866 | N/A |
6/30/2017 | 32,370 | 5,368 | N/A | 4,779 | N/A |
3/31/2017 | 32,146 | 4,789 | N/A | 5,285 | N/A |
12/31/2016 | 31,480 | 4,135 | N/A | 5,292 | N/A |
9/30/2016 | 28,015 | 3,208 | N/A | 5,002 | N/A |
6/30/2016 | 24,288 | 2,376 | N/A | 4,126 | N/A |
3/31/2016 | 21,442 | 2,592 | N/A | 3,809 | N/A |
12/31/2015 | 18,968 | 2,834 | N/A | 3,864 | N/A |
9/30/2015 | 19,010 | 2,706 | N/A | 3,973 | N/A |
6/30/2015 | 19,382 | 2,963 | N/A | 4,291 | N/A |
3/31/2015 | 19,160 | 2,800 | N/A | 4,321 | N/A |
12/31/2014 | 19,173 | 2,853 | N/A | 4,496 | N/A |
9/30/2014 | 19,522 | 3,296 | N/A | 4,508 | N/A |
6/30/2014 | 19,514 | 3,427 | N/A | 4,310 | N/A |
3/31/2014 | 19,376 | 3,539 | N/A | 4,359 | N/A |
12/31/2013 | 19,277 | 3,758 | N/A | 4,022 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei van CB ( 0.7% per jaar) ligt onder de spaarquote ( 2.5% ).
Winst versus markt: De winst van CB ( 0.7% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.2% per jaar).
Hoge groeiwinsten: De winst van CB zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van CB zal naar verwachting de komende 3 jaar dalen ( -0.05% per jaar).
Hoge groei-inkomsten: De omzet van CB zal naar verwachting de komende 3 jaar dalen ( -0.05% per jaar).
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen CB zal naar verwachting over 3 jaar laag zijn ( 12.8 %).